Codrituzumab (Anti-GPC3 / Glypican-3)

Ask supplier a question | View on supplier's website

Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3) which is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth. MW: 150 KD.

Supplier	Selleck Chemicals
Product #	A2476
Sku #	A2476-1mg
Pricing	1mg, $270.00

Feedback